Company
Synaptic
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
5
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Synaptic, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Synaptic.
Latest FDA decisions
K233900 · Decided Sep 6, 2024 · 270 days after receipt
Device type: Catheter, Electrode Recording, Or Probe, Electrode Recording (DRF) · Cardiology
K240246 · Decided Jul 26, 2024 · 178 days after receipt
Device type: Trocar (DRC) · Cardiology
K233708 · Decided Feb 16, 2024 · 88 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
K203793 · Decided Feb 14, 2022 · 413 days after receipt
Device type: Catheter, Electrode Recording, Or Probe, Electrode Recording (DRF) · Cardiology
K151936 · Decided Dec 4, 2015 · 143 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Treatment of PAF With the Synaptic SystemActive, not recruiting
NCT05905835 · 128 participants · Start Sep 20, 2023 · Primary completion Nov 5, 2025
Device: Synaptic Cryoablation System · For: Paroxysmal Atrial Fibrillation
Sites: Phoenix, Arizona; Jonesboro, Arkansas; Los Angeles, California · 10 sites in all
- Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary HypertensionPivotal-lookingStatus unknown
NCT03511313 · 264 participants (planned) · Start Apr 11, 2018 · Primary completion Jun 2020
Device: Renal denervation · For: Primary Hypertension
Sites: Beijing, China
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1440-2012 · Started Jul 18, 2008 · Posted by FDA Apr 19, 2012
Reason given: Device was distributed without marketing approval.
Cause as FDA categorized it: PMA · Device type: Stimulator, Nerve, Transcutaneous, For Pain Relief (GZJ)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.